Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aquestive Therapeutics Q2 2024 GAAP EPS $(0.03) Beats $(0.11) Estimate, Sales $20.099M Beat $12.380M Estimate

Author: Benzinga Newsdesk | August 06, 2024 05:30pm
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.11) by 72.73 percent. The company reported quarterly sales of $20.099 million which beat the analyst consensus estimate of $12.380 million by 62.35 percent. This is a 51.79 percent increase over sales of $13.241 million the same period last year.

Posted In: AQST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist